{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:19:14Z","timestamp":1769264354033,"version":"3.49.0"},"reference-count":12,"publisher":"American Diabetes Association","issue":"9","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,9,1]]},"abstract":"<jats:p>OBJECTIVE\u2014To further define clinical features associated with the syndrome of diabetes and pancreatic exocrine dysfunction due to mutations in the carboxyl-ester lipase (CEL) gene and to assess the effects of pancreatic enzyme substitution therapy.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014Nine patients with CEL gene mutation, exocrine deficiency, and diabetes were treated and followed for 30 months.<\/jats:p>\n               <jats:p>RESULTS\u2014Treatment improved symptoms in seven of nine patients. Exocrine and endocrine function assessed by fecal elastase and A1C were not affected, although fecal lipid excretion was reduced. Vitamin E was low in all patients but increased with treatment (P &amp;lt; 0.001 at 30 months) and improved in five subjects. A predominantly demyelinating neuropathy was seen in a majority of patients, and carpal tunnel syndrome was common.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014Pancreatic enzyme substitution alleviated symptoms and malabsorption and normalized vitamin E levels. Glycemic control was not significantly affected. The CEL syndrome seems associated with a demyelinating neuropathology.<\/jats:p>","DOI":"10.2337\/dc07-2217","type":"journal-article","created":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T00:12:41Z","timestamp":1213315961000},"page":"1738-1740","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":14,"title":["Neurological Features and Enzyme Therapy in Patients With Endocrine and Exocrine Pancreas Dysfunction Due to <i>CEL<\/i> Mutations"],"prefix":"10.2337","volume":"31","author":[{"given":"Mette","family":"Vesterhus","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Pediatrics, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helge","family":"R\u00e6der","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Pediatrics, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Aurlien","sequence":"additional","affiliation":[{"name":"Department of Neurology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara G.","family":"Gjesdal","sequence":"additional","affiliation":[{"name":"Institute of Medicine, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilie","family":"Bredrup","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pa\u030al I.","family":"Holm","sequence":"additional","affiliation":[{"name":"Institute of Medicine, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Molven","sequence":"additional","affiliation":[{"name":"Gade Institute, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Bindoff","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Neurology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold","family":"Berstad","sequence":"additional","affiliation":[{"name":"Institute of Medicine, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pa\u030al R.","family":"Nj\u00f8lstad","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Pediatrics, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031218252963800_R1","doi-asserted-by":"crossref","unstructured":"Raeder H, Johansson S, Holm PI, Haldorsen IS, Mas E, Sbarra V, Nermoen I, Eide SA, Grevle L, Bj\u00f8rkhaug L, Sagen JV, Aksnes L, S\u00f8vik O, Lombardo D, Molven A, Nj\u00f8lstad PR: Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet\u200838:54\u201362, 2006","DOI":"10.1038\/ng1708"},{"key":"2022031218252963800_R2","doi-asserted-by":"crossref","unstructured":"Raeder H, Haldorsen IS, Ersland L, Gruner R, Taxt T, S\u00f8vik O, Molven A, Nj\u00f8lstad PR: Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes\u200856:444\u2013449, 2007","DOI":"10.2337\/db06-0859"},{"key":"2022031218252963800_R3","doi-asserted-by":"crossref","unstructured":"Ewald N, Bretzel RG, Fantus IG, Hollenhorst M, Kloer HU, Hardt PD, the Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: results of a prospective multi-centre trial. Diabetes Metab Res Rev\u200823:386\u2013391, 2007","DOI":"10.1002\/dmrr.708"},{"key":"2022031218252963800_R4","doi-asserted-by":"crossref","unstructured":"Hardt PD, Hauenschild A, Jaeger C, Teichmann J, Bretzel RG, Kloer HU: High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. Dig Dis Sci\u200848:1688\u20131692, 2003","DOI":"10.1023\/A:1025422423435"},{"key":"2022031218252963800_R5","doi-asserted-by":"crossref","unstructured":"Haldorsen IS, Vesterhus M, R\u00e6der H, Jensen DK, S\u00f8vik O, Molven A, Nj\u00f8lstad PR: Lack of pancreatic body and tail in HNF1B mutation carriers. Diabet Med\u200825:782\u2013787, 2008","DOI":"10.1111\/j.1464-5491.2008.02460.x"},{"key":"2022031218252963800_R6","doi-asserted-by":"crossref","unstructured":"Vesterhus M, Raeder H, Johansson S, Molven A, Nj\u00f8lstad PR: Pancreatic exocrine dysfunction in maturity-onset diabetes of the young type 3. Diabetes Care\u200831:306\u2013310, 2008","DOI":"10.2337\/dc07-1002"},{"key":"2022031218252963800_R7","doi-asserted-by":"crossref","unstructured":"Creutzfeldt W, Gleichmann D, Otto J, Stockmann F, Maisonneuve P, Lankisch PG: Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion\u200872:71\u201375, 2005","DOI":"10.1159\/000087660"},{"key":"2022031218252963800_R8","doi-asserted-by":"crossref","unstructured":"Cavalot F, Bonomo K, Perna P, Bacillo E, Salacone P, Gallo M, Mattiello L, Trovati M, Gaia E: Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual \u03b2-cell secretion and metabolic control in type 1 diabetic subjects (Letter). Diabetes Care\u200827:2052\u20132054, 2004","DOI":"10.2337\/diacare.27.8.2052"},{"key":"2022031218252963800_R9","doi-asserted-by":"crossref","unstructured":"Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M: Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med\u2008333:89\u201394, 1995","DOI":"10.1056\/NEJM199507133330203"},{"key":"2022031218252963800_R10","doi-asserted-by":"crossref","unstructured":"Sharma KR, Cross J, Farronay O, Ayyar DR, Shebert RT, Bradley WG: Demyelinating neuropathy in diabetes mellitus. Arch Neurol\u200859:758\u2013765, 2002","DOI":"10.1001\/archneur.59.5.758"},{"key":"2022031218252963800_R11","doi-asserted-by":"crossref","unstructured":"Harding AE, Matthews S, Jones S, Ellis CJ, Booth IW, Muller DP: Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N Engl J Med\u2008313:32\u201335, 1985","DOI":"10.1056\/NEJM198507043130107"},{"key":"2022031218252963800_R12","doi-asserted-by":"crossref","unstructured":"Martinello F, Fardin P, Ottina M, Ricchieri GL, Koenig M, Cavalier L, Trevisan CP: Supplemental therapy in isolated vitamin E deficiency improves the peripheral neuropathy and prevents the progression of ataxia. J Neurol Sci\u2008156:177\u2013179, 1998","DOI":"10.1016\/S0022-510X(98)00038-0"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/9\/1738\/599707\/zdc00908001738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/9\/1738\/599707\/zdc00908001738.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T19:26:11Z","timestamp":1647113171000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/31\/9\/1738\/27952\/Neurological-Features-and-Enzyme-Therapy-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,1]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc07-2217","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,1]]}}}